Skip to nav Skip to content

Clinical Trial Search

307 Clinical Trials Found

Clinical Trial 22617

Disease Site: Breast
PI: Soyano Muller, Aixa

Clinical Trial 23103

An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera
Disease Site: Other
PI: Kuykendall, Andrew

Clinical Trial 23116

Disease Site: Eye and Orbit
PI: Khushalani, Nikhil

Clinical Trial 19829

Disease Site: Lymphoid Leukemia, Non-Hodgkin's Lymphoma
PI: Shah, Bijal

Clinical Trial 21139

A Phase IIA Study of Sequential ("first strike, second strike") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer
Disease Site: Prostate
PI: Zhang, Jingsong

Clinical Trial 21192

A Phase 2 Study of the Combination Dostarlimab with Niraparib In Patients with Penile Carcinoma Who Have Progressed Following Chemotherapy
Disease Site: Other Male Genital
PI: Chahoud, Jad

Clinical Trial 21665

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine And Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Disease Site: Other Digestive Organ, Pancreas
PI: Strosberg, Jonathan

Clinical Trial 22092

A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) in Combination with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib (MK-7339), Compared to Concurrent Chemoradiation Therapy Alone in Participants with Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC).
Disease Site: Lung
PI: Chiappori, Alberto

Clinical Trial 23104

Disease Site: Leukemia, other
PI: Deutsch, Yehuda

Clinical Trial 21937

A Prospective, Multi-Center, Randomized, Double-Arm Trial to Determine the Impact of the SELENE System on Positive Margin Rates in Breast Conservation Surgery
Disease Site: Breast
PI: Lee, Marie

Clinical Trial 21681

Disease Site: Brain and Nervous System
PI: Vogelbaum, Michael

Clinical Trial 19658

A Phase 1, Open-Label, Dose-Escalation with Expansion Study of SX-682 in Subjects with Myelodysplastic Syndrome Who Had Disease Progression or are Intolerant to Prior Therapy
Disease Site: Myelodysplastic syndrome (MDS), Leukemia, other
PI: Sallman, David